New study links metabolic syndrome to higher cancer risk

A new study has found that individuals with metabolic syndrome, a cluster of conditions affecting heart, kidney, and metabolic health, may face a higher risk of developing cancer, particularly in more advanced stages of the condition.

The research, published in Circulation: Population Health and Outcomes, suggests that people with severe cardiovascular-kidney-metabolic (CKM) syndrome could have nearly a 30% increased risk of cancer compared to those without the condition.

CKM syndrome includes a combination of health issues such as high blood pressure, abnormal cholesterol levels, elevated blood sugar, excess body weight, and reduced kidney function. 

These factors are often interconnected and collectively contribute to broader health complications.

Researchers analyzed data from nearly 1.4 million individuals in Japan over a period of more than three years. 

The findings showed a clear pattern: cancer risk rose in line with the severity of CKM syndrome. 

Individuals in early stages showed a modest increase in risk, while those in advanced stages experienced significantly higher rates.

Lead researcher Dr. Hidehiro Kaneko said the overlap in risk factors across cardiovascular, kidney, and metabolic systems may explain the association.

“Dysfunction in each of these systems is independently associated with cancer risk due to shared risk factors,” he said.

The study also highlights how widespread these conditions are, with scientists estimating that a large proportion of adults have at least one component of CKM syndrome.

Experts said the findings reinforce the importance of preventive health measures, including regular screenings and lifestyle changes such as maintaining a healthy weight, managing blood pressure, and controlling blood sugar levels.